SETPOINT · START ACTIVATING

The Challenge: How do you launch a revolutionary approach to rheumatoid arthritis in a category dominated by pharmaceutical sameness? SetPoint needed a brand as unconventional as its science.

The Move: Start Activating. We created SetPoint's brand from the first spark to its full expression, turning a breakthrough device in immune regulation into a powerful story of renewed possibility. Bold color, kinetic arrows, and expressive illustrations brought the science to life, and made the brand impossible to confuse with anything else in the category.

The Return: Worldwide recognition of a brand that broke the mold: FDA approval in 2025, expanded pathways to patient access, and a spot on the list of Fast Company's 2026 Next Big Things in Tech.

We launched the fresh new Cordis brand across multiple product verticals—each with their own messaging and premium visual aesthetic. Below is a snapshot of the work for their vascular closure line of products called Mynx. ⌁

© 2026 Tony Johnson. All Rights Reserved.